277 related articles for article (PubMed ID: 1198095)
1. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
Reddy JK; Krishnakantha TP
Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
[TBL] [Abstract][Full Text] [Related]
2. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
Reddy JK; Azarnoff DL; Sirtori CR
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
[TBL] [Abstract][Full Text] [Related]
3. Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouse.
Reddy JK; Moody DE; Azarnoff DL; Tomarelli RM
Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):51-7. PubMed ID: 851495
[TBL] [Abstract][Full Text] [Related]
4. Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat.
Lazarow PB
Science; 1977 Aug; 197(4303):580-1. PubMed ID: 195342
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents.
Moody DE; Reddy JK; Azarnoff DL
Biochem Pharmacol; 1984 Aug; 33(16):2591-7. PubMed ID: 6431985
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
[TBL] [Abstract][Full Text] [Related]
7. Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs.
Reddy MK; Lalwani ND; Qureshi SA; Reddy JK
Hum Toxicol; 1982 Mar; 1(2):135-47. PubMed ID: 7173894
[TBL] [Abstract][Full Text] [Related]
8. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
Moody DE; Reddy JK
Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
[TBL] [Abstract][Full Text] [Related]
9. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
Reddy J; Svoboda D; Azarnoff D
Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
[No Abstract] [Full Text] [Related]
10. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
[TBL] [Abstract][Full Text] [Related]
11. Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast.
Schiestl RH; Reddy JK
Carcinogenesis; 1990 Jan; 11(1):173-6. PubMed ID: 2403857
[TBL] [Abstract][Full Text] [Related]
12. Induction of hepatic ornithine decarboxylase by hypolipidemic drugs with hepatic peroxisome proliferative activity.
Izumi K; Reddy JK; Oyasu R
Carcinogenesis; 1981; 2(7):623-7. PubMed ID: 7273341
[TBL] [Abstract][Full Text] [Related]
13. Changes to the integral membrane protein composition of mouse liver peroxisomes in response to the peroxisome proliferators clofibrate, Wy-14,643 and di(2-ethyl-hexyl)phthalate.
Crane DI; Chen N; Masters C
Mol Cell Biochem; 1988 May; 81(1):29-36. PubMed ID: 3173343
[TBL] [Abstract][Full Text] [Related]
14. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens.
Reddy JK; Azarnoff DL; Hignite CE
Nature; 1980 Jan; 283(5745):397-8. PubMed ID: 6766207
[No Abstract] [Full Text] [Related]
15. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
Reddy JK; Azarnoff DL; Svoboda DJ; Prasad JD
J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071
[TBL] [Abstract][Full Text] [Related]
16. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver.
Reddy JK; Rao MS; Azarnoff DL; Sell S
Cancer Res; 1979 Jan; 39(1):152-61. PubMed ID: 83907
[No Abstract] [Full Text] [Related]
17. Partial purification and immunoreactivity of an 80 000-molecular-weight polypeptide associated with peroxisome proliferation in rat liver.
Reddy MK; Hollenberg PF; Reddy JK
Biochem J; 1980 Jun; 188(3):731-40. PubMed ID: 6781475
[TBL] [Abstract][Full Text] [Related]
18. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
Reddy JK
Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
[TBL] [Abstract][Full Text] [Related]
19. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
Warren JR; Simmon VF; Reddy JK
Cancer Res; 1980 Jan; 40(1):36-41. PubMed ID: 6765917
[No Abstract] [Full Text] [Related]
20. Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
Lazarow PB; Shio H; Leroy-Houyet MA
J Lipid Res; 1982 Feb; 23(2):317-26. PubMed ID: 7077146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
